The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

BRAF(V600E) mutations occur in ~10% of colorectal cancer (CRC) cases, are associated with poor survival and have limited responses to BRAF/MEK inhibition with or without EGFR inhibition. There is an unmet need to understand the biology of poor prognostic BRAFMT CRC. We have used differential gene ex...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Autores principales: Forsythe, Nicholas, Refaat, Alaa, Javadi, Arman, Khawaja, Hajrah, Weir, Jessica-Anne, Emam, Heba, Allen, Wendy L., Burkamp, Frank, Popovici, Vlad, Jithesh, Puthen V., Isella, Claudio, Labonte, Melissa J., Mills, Ian G., Johnston, Patrick G., Van Schaeybroeck, Sandra
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5985931/
https://ncbi.nlm.nih.gov/pubmed/29483217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0603
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares